Abstract: Until recently, actin was thought to act merely as a passive track for its motility partner, myosin, during actomyosin interactions. Yet a recent report having observed dynamical conformational changes in labeled skeletal muscle a-actin suggests that actin has a more active role. Because the labeling technique was still immature, however, conclusions regarding the signicance of the dierent conformations are difcult to make. Here, we describe the preparation of fully active a-actin obtained from a baculovirus expression system. We developed a-actin recombinants, of which subdomains 1 and 2 have specic sites for uorescent probes. This specic labeling technique oers to signicantly expand the information acquired from actin studies.
Introduction
Actins are highly conserved cytoplasmic proteins found in all eukaryotes and are involved in many critical physiological functions including muscle contraction. There exist many dierent actin isoforms, several of which have been puried from various animal, plant, and fungal species. 1) Overall, three main actin isoforms have been identied: a, b and . All three have high amino acid conservation (>90 percent) and take similar structures. In cells, actin normally takes one of two lament types: microlaments, which are one of the three major components in the cytoskeleton, are made up of b-and -actin; and thin laments, which are an essential component of the contractile apparatus in muscle, are made up of a-actin.
Striated muscle myobrils (actomyosin lament bundles) represent the most extensively studied contractile network in eukaryotic cells. In vitro studies of myobrils at low ionic strength found actin takes its monomeric form, while at high ionic strength actin is lamentous. The change in actin state is important as various physiological processes like chemotaxis and cytokinesis require that actin be kept in dynamical equilibrium, constantly polymerizing and depolymerizing.
Among actin, the most well studied is the vertebrate a-skeletal muscle isoform, which makes up twenty percent or more of the total protein in muscle. Because techniques for highly puried actin and myosin from muscle are readily available, many physiological and biochemical studies investigating the actomyosin interaction mechanism have been reported, 2) although most of these reports took a greater interest in myosin. This is because actin has often been thought to have a passive role in myosin motility, acting merely as a track for the myosin to transverse.
However, by using dierent techniques, Oda et al. and we separately reported that actin is not passive. Noting that the structure of an actin monomer unit is dierent between G-actin (monomeric form) and F-actin (lamentous form), Oda et al. showed in a model that there was a conformational transition state from G-actin to F-actin. 3) We showed actin dynamic states conform in the span of seconds. 4) These results suggest that actin may play a more active role in the actomyosin complex. Yet the necessary experiments needed to conrm this theory have to date proven impractical. One reason is the difculty in binding a uorescent label to specic actin positions in order to detect intra-molecule uctuations without a loss in actin activity. Recombinant actin has the potential to overcome this problem. However, despite multiple reports describing the expression of recombinant b-actins in Dictyostelium discoideum, Drosophila, Arabidopsis thaliana and Yeast, 5)-7) very few techniques have proven useful for the expression and purication of mammalian a-actin recombinants and their mutants, and even then with limited success. 8)-10) For example, techniques that used myoblast cells and an in vitro expression system had recombinants that had low purication yields, mostly because high ion concentrations had to be used resulting in recombinant and endogenous actin mixing to form heterogeneous laments. 9) Furthermore, techniques that expressed recombinants from the E. coli system often suer from inclusion bodies. 11) Here we describe a baculovirus expression system that overcomes these problems by constructing two types of a-actin recombinants connected to a Flag-tag for purication at low ionic strength. Thymosin b4, an actin monomer binding protein, was fused to a-actin via a exible peptide in order to obstruct actin lament formation. We also made cysteine substitution a-actin mutants for uorescent labeling at specic actin sites. We are currently testing the viability of these recombinant a-actins in single molecule uorescence resonance energy transfer (smFRET) studies regarding the actomyosin complex with the expectation that these new recombinant mammalian actins will be applicable to an array of new actin studies.
Materials and methods
Rat a-actin cDNA. a-actin cDNA was obtained from a rat skeletal muscle full-length cDNA library (Seegene Inc., Korea) using PCR amplication. Primers for the PCR amplication were as follows.
Rat a-actin Forward Nco I (5' GACACCATG-GGTGACGAGGACGAGAC 3') and rat a-actin Reverse (5' GTGCGCCTAGAAGCATTTGCGGT-GC 3').
Construction of baculovirus expression plasmids. 3 Ã Flag-a-actin: the obtained actin coding sequence (see Rat a-actin cDNA, Materials and methods) was inserted into pFastBac1 (Invitrogen, USA) between the Bam HI and Eco RI sites with a 3 Ã Flag-tag sequence at the 5' terminal of the rat aactin gene. The 3 Ã Flag-tag sequence was created by annealing the two oligonucleotides, 3
Ã Flag-tag Forward (5' GATCGATGGACTACAAAGACCATGA-CGGTGATTATAAAGATCATGACATCGATTA-CAAGGATGACGATGACAAGCGATCCATG 3') and 3 Ã Flag-tag Reverse (5' AATTCATGGATCGC-TTGTCATCGTCATCCTTGTAATCGATG TCA-TGATCTTTATAATCACCGTCATGGTCTTTG-TAGTCCATC 3') together (Fig. 1A-1) .
a-actin-thymosin-Flag: the obtained a-actin coding sequence and Flag-tag sequence (the gene corresponding to the D-Y-K-D-D-D-D-K peptide) were inserted into pFastBac1 in series. The thrombin recognition-thymosin-b4 fragment, which is a G-actin binding peptide, was inserted between actin and the Flag-tag. The thrombin recognition-thymosin-b4 fragment was created by rst annealing separately thrombin-FC Forward (5' CTAGCCTGGTTCCG-CG TGGATCCGGAGGAGCAGGAGGAATGTC-TGACAAACCCGATATGGCTGAGATCGAGAA-ATTCGATAAGT 3') with thrombin-FC Reverse (5' GTTTCGACTTATCGAATTTCTCGATCTCAG-CCATATCGGGTTTGTCAGACATTCCTCCTG-CTCCTCCGGATCCACGCGGAACCAGG 3') and FC-thymosin b4 Forward (5' CGAAACTGAAGAA-GACAGAGACGCAAGA GAAAAATCCACTGC-CTTCCAAAGAAACGATTGAACAGGAGAAGC-AAGCAGGCGAATCGTAACTGCA 3') with FCthymosin b4 Reverse (5' GTTACGATTCGCCTGC-TTGCTTCTCCTGTTCAATCGTTTCTTTGGA-AGGCAGTGGATTTTTCTCTTGCGTCTCTGT-CTTCTTCA 3'), and then ligating the two annealed sets together. The thrombin recognition-thymosin-b4 fragment contained a glycine-rich exible chain (FC: 5 mer, G-G-A-G-G) peptide between the thrombin recognition site and thymosin ( Fig. 1A-2) .
Mutant constructs. Mutant rat a-actin constructs (Q41C, C374A, Q41CC374A) were created using site-directed mutagenesis (QuikChange SiteDirected Mutagenesis Kit, Strategene, USA) using appropriately designed oligonucleotides and 3 Ã Flaga-actin parental constructs.
Cell culture. Sf9 insect cells were maintained in a monolayer culture in ventilated 175 cm 2 asks at 28 C with 10 % FBS (Invitrogen)-GIBCO0 Antibiotic-Antimycotic liquid (Invitrogen)/EX-Cell 420 (SAFC Biosciences, USA). The cells were routinely sub-cultured every 2{3 days to maintain log growth phase. Cells were replaced with frozen stocks approximately every 2 months.
Protein purication. All steps were performed at less than 4 C. Cells were collected for 60 hrs post-infection by centrifugation at 6,000 Ã g for 5 min and stored at À80
C. Frozen cells were sus-pended in 10 ml/g cells of Lysis solution (10 mM HEPES-NaOH pH 7.5, 10 mM NaCl, 1 mM EGTA, 0.1 mM MgCl 2 , 1 mM ATP, 0.05 mM DTT containing the protease inhibitor mix, Complete, EDTA-free (Roche Diagnostics, Switzerland)) and sonicated immediately afterward. After ultra centrifugation at 10,000 Ã g for 20 min, soluble fractions were run through 200 ml/g cell in an anti-Flag M2 Afnity Gel (Sigma Aldrich, USA), and then washed thoroughly with Wash solution (10 mM HEPES-NaOH pH 7.5, 10 mM NaCl, 0.1 mM EGTA, 0.1 mM MgCl 2 , 1 mM ATP). We applied two dierent methods to purify rat actin. In the rst method, the 3 Ã Flag-aactin was eluted from the resin in competition with the 3 Ã Flag peptide (Sigma Aldrich). Rat a-actin recombinant and its mutants were separated from the Flag-a-actin; arrowhead shows the position of the a-actin after the tag was removed. (C) Purication of a-actin before and after treatment with thrombin protease was checked using SDS-PAGE (12.5 percent concentration) and CBB staining (lanes 1, 2). Arrow and arrowhead point to a-actin and biotinylated thrombin, respectively. For both B and C, approximately 3 mg were loaded onto each lane.
3
Ã Flag-tag sequence by treatment with Enterokinase (Novagen, Germany) treatment for 30 hrs at 20 C. In the second method, rat a-actin recombinant was also obtained from a-actin-thymosin-Flag, which was bound to an anti-Flag M2 afnity Gel via biotinylated human thrombin (Novagen, Germany) treatment for 2 hrs at room temperature without Flag peptide competition. The biotinylated thrombin was then removed from actin by using Streptavidin Agarose (Novagen).
Recombinant protein analysis. SDS-PAGE: Puried a-actin recombinant and its mutants were analyzed by SDS-polyacrylamide gel electorophoresis. The gels were stained by the CBB staining solution Quick-CBB (Wako, Japan). Immunoblot analysis was done by using an anti-Flag polyclonal antibody (Sigma Aldrich), VECTASTEIN Elite ABC Kit and DAB Substrate Kit (Vector lab. Inc., USA). In addition, puried a-actin recombinant and its mutants were labeled by Alexa Fluor 555 C2 maleimide (Invitrogen). The relative band intensities of CBB and Alexa Fluor 555 were determined with Molecular Imager FX (Bio-Rad, USA).
In vitro motility assay: Puried a-actin recombinant, which was separated from a-actin-ThymosinFlag using thrombin protease, polymerized at high potassium concentrations (>100 mM). Actin laments were labeled with a phalloidin-tetramethylrhodamine B isothiocyanate conjugate (Fluka, USA). Rabbit skeletal muscle actin was used as a control. In addition, actin laments were made by copolymerizing Alexa Fluor 555-labeled a-actin recombinant with unlabeled rabbit skeletal muscle actin at a 1 to 50 ratio at high ionic strength. Motility assays were performed in solution containing 20 mM HEPES-KOH (pH 7.8), 25 mM KCl, 5 mM MgCl 2 , 1 mM ATP and an oxygen scavenging system to reduce photo-bleaching at 25 C using rabbit skeletal muscle Heavy MeroMyosin (HMM) with some modications. 12) Skeletal muscle HMM and actin were obtained from rabbit skeletal muscle and puried according to Margossian et al. 13) and Spudich & Watt, 14) respectively.
Results and discussion
Production of a-actin recombinants. Conventional actins play an important role in cell function in all eukaryotes, often through polymerizationdepolymerization dynamics. In in vitro experiments, polymerization-depolymerization equilibrium can be controlled by manipulating the concentration of cations like Ca 2þ and Mg 2þ . In general, recombinants are a popular tool for the study of proteins, including actin. All actin have a highly conserved amino acid sequence and form laments (lamentation) at high ionic concentrations. Filamentation complicates actin studies since this property makes the purication of tag-fused actin recombinant from a host cell using specic afnity chromatography difcult. Here we discuss the construction of two types of a-actin recombinants. For both our recombinants, the rat a-actin gene was obtained from a rat skeletal muscle cDNA library using PCR amplication methods. The sequence of the obtained a-actin gene was in accordance with information from Gene Bank (accession no. BC061974.1). Initially, we tried to express His-tag fused a-actin recombinant using the method from Anthony et al., 9) but could not elute it from Ni 2þ -afnity columns at high imidazole ion levels. To resolve this, we constructed Flag-tag fused a-actin recombinant which could be puried at low ionic strengths. Fig. 1A-1 and 2 show two a-actin recombinant constructs. The Flag-tag is an articial and sensitive epitope that can be used for afnity chromatography. 3 Ã Flag-tag is a more sensitive version and contains an enterokinase cleavage site between the 3 Ã Flag and a-actin (Fig. 1A) . After enterokinase treatment, an Arg-Ser peptide was fused to a-actin recombinant at the N-terminus. We also included methionine and glycine residues, both of which exist at the N-terminus in skeletal muscle actin but are removed during translation to form the mature terminus. 15) Consequently, our obtained a-actin recombinant has 4 additional amino acid residues (Arg, Ser, Met, Gly) at the N-terminus relative to mature skeletal muscle actin. In the other a-actin construct, thymosin b4, which is a monomeric actin specic binding protein, 16 ) was fused to a-actin at the C terminus in order to disturb polymerization in SF9 cells. We also inserted the specic protease thrombin recognition site and a exible Gly-rich peptide, which supports the binding of a-actin to thymosin, between a-actin and thymosin b4 (Fig. 1A-2) . This a-actin construct is monomeric until the cell extract is attached to the anti-Flag M2 Afnity Gel.
From both purications, we obtained about 0.3 mg of soluble peptide a-actin recombinant from 1 g of wet SF9 cells using a ask culture. However, the suspension culture accelerated the formation of inso-luble inclusion bodies. Therefore, we substituted the Cys from the additional 4 residues at the N-terminus with Gly. However, the actin N-terminus acidic cluster and especially the exchanged Cys residue are thought to be important for actin myosin interactions. 17)- 19) In fact, the Cys residue is well conserved in most a-actin types. There are exceptions, though. It is absent in some b-actin and replaced with Gly in non-muscle and amoeba. 20),21) Furthermore, it is deleted post modication in mature muscle actin. Figure  1B shows SDS-PAGE and immunoblot results of puried recombinants. Using CBB staining, 3
Ã Flaga-actin was detected as the main band around 45 kDa (Fig. 1B, lane1 arrow) . Following enterokinase treatment, the main band migrated to 43 kDa, which is equivalent to the molecular weight of monomeric a-actin recombinant (Fig. 1B, lane2 arrowhead) . The 45 kDa band was detected by immunoblot analysis using specic anti-Flag polyclonal antibody (Fig.  1B, lane3 ) but became much weaker after enterokinase treatment, suggesting the Flag-tag was removed (Fig. 1B, lane4 ). Skeletal muscle a-actin exists as a polymer at physiological conditions in cells and forms laments at high ionic strength in vitro. The polymerization of 3 Ã Flag-a-actin and a-actin, respectively, was examined at 0.1 M KCl. Actin polymers were easily seen using uorescence microscopy following labeling with a phalloidin-tetramethyl rhodamine B isothiocyanate conjugate. The a-actin recombinant then formed laments of similar length to rabbit skeletal muscle actin (data not shown). On the other hand, obvious laments were not detected from enterokinase untreated 3 Ã Flag-a-actin (data not shown). The actin N terminus, where the 3 Ã Flag-tag is placed, is important for both the formation of the acto-myosin complex 19) and polymerization. 22) Enterokinase treatment separates the 3 Ã Flag-tag from the a-actin recombinant. Despite having two additional amino acids, Arg and Ser, a-actin recombinant polymerization was unperturbed.
The second a-actin recombinant construct we used was an a-actin-thymosin fused protein. This recombinant is easy to separate from endogenous actins and can be puried in a short time. Thymosin fused-a-actin cannot form laments. Figure 1C shows an SDS-PAGE following a-actin purication from the thymosin fused recombinant. After biotinylated thrombin digestion (Fig. 1C, lane1) and Streptavidin Agarose treatment, a-actin appeared as the main band (Fig. 1C, lane2 ). The puried a-actin recombinant, which had no additional amino acid residues at the N-terminus but 7 additional amino acid residues (P-A-S-L-V-P-R) at the C-terminus, had sufcient polymerization activity (data not shown). If the digestive treatment is applied for only a short period, then thrombin can be used whereas enterokinase cannot. Furthermore, unlike enterokinase, biotinylated thrombin treatment can be applied in the presence of ATP for a short time without compromising polymerization. 23) Biotinylated thrombin can be separated from a-actin recombinant easily using Streptavidin Agarose.
In vitro motility assay. The in vitro motility assay 24) is a common assay applied to examine the interaction between puried myosin and recombinant actin. In this assay, myosin molecules bound to the coverslip bind tightly to uorescently labeledactin laments in the absence of ATP. When ATP is added to the system, myosin begins to move along the actin laments. Figure 2A shows the sliding velocities of a-actin laments from a-actin-Thymosin-Flag propelled by rabbit skeletal muscle myosin HMM bound to the surface of a nitrocellulose-coated coverslip. The velocity was 6.25 e 1.82 mm/s (arithmetic mean e SD, n ¼ 684) at 25
C. This result is consistent with the velocity of wild type skeletal muscle actin lament (Fig. 2B, 6 .31 e 1.86, mm/s (arithmetic mean e SD, n ¼ 667)) indicating that our recombinant a-actin interacts similarly to wild type with rabbit skeletal muscle myosin. Similar results were found using a-actin recombinant treated with enterokinase (data not shown). These data show that substituting Cys for Gly does not aect velocity.
a-actin Cys mutants and specic labeling. In general, actin laments have often been thought to be nothing more than passive rails for myosin to move and generate force in many necessary cell activities like muscle contraction. However, a recent report found that actin laments make dynamical changes between conformational states. 4) To pursue this matter further, we did smFRET experiments using actin mutants with uorescent labeling at specic positions (Morimatsu M. et al. unpublished data). Figure 3A shows the crystal structure of rabbit aactin, which has four subdomains. The red and green indicate subdomains 1 and 2, respectively. We constructed actin Cys-mutants using 3 Ã Flag-a-actin recombinant as a parental construct for uorescent labeling. Gln41 (yellow ball) and Cys374 (orange ball where the thiol group of Cys374 is shown) were chosen as the uorescent labeling positions since the region around Gln41 is considered to be important for actomyosin recognition 25) and because of Cys 374's known reactivity. 26),27) Figure 3B shows the main band (approximately 43 kDa) of the SDS-PAGE uorescent image using Alexa Fluor 555 (upper) and CBB staining (lower). WT, Q41C and Q41CC374A were detected by Alexa Fluor 555 uorescence, but C374A was not. There are ve cysteine residues in skeletal muscle actin. According to G-actin crystal structure analysis, the thiol groups from Cys10, Cys217 and Cys257 are always directed into the actin molecule whereas that from Cys 374 points outward and that from Cys285 is unknown. Because Q41C but not C374A was successfully labeled by Alexa Fluor 555 C2 maleimide, we concluded that Q41C was labeled with uorescent dyes at positions 41 and 374, while WT was labeled at position 374. It should be noted, the bands of all actins except C374A mutant showed a mobility shift by Alexa Fluor 555 labeling on SDS-PAGE (data not shown).
Finally, we tried to co-polymerize and observe Alexa Flour 555 labeled Q41C mutants with unlabeled rabbit skeletal muscle actin at a ratio of 1 to 50 using uorescence microscopy (Fig. 3D) . Brindle actin laments (Fig. 3C) were seen to successfully interact with rabbit myosin HMM in in vitro motility assays (Fig. 3D) . We conrmed that the obtained aactin recombinant could form not only laments by itself but also co-laments with rabbit skeletal muscle actin.
During lamentation, the transition from ATP to ADP bound actin is accompanied by a conformational change in actin subdomain 2, or more specically in the D loop (DNase I binding loop) located at the top of subdomain 2. 25) Within the D loop exist several structures including an a-helical structure. Moreover, large conformational changes around Q41 have also been observed in molecular dynamics simulations. 28) Using the specic actin mutants described here and smFRET techniques, the dynamic conformational uctuations of actin laments can potentially be analyzed (detailed analysis to be published) and thus elucidate more information regarding the active role of actin laments in muscle contraction. 29),30) 
